INS and diabetes mellitus: A number of studies suggest that IL-1β is implicated in the development of insulin resistance in diabetes mellitus [31,32] The notion is supported by the finding that blocking of IL-1 signaling pathways in insulin-resistant patients with diabetes mellitus by treatment with IL-1 receptor antagonist Anakinra resulted in sustained improvement in insulin sensitivity [33].